Amal Kumar Dhara,
Amit Kumar Nayak
Elsevier Science
e druk, 2022
9780323918145
Viral Infections and Antiviral Therapies
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2022
ISBN13: 9780323918145
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.
Specificaties
Inhoudsopgave
<p>Section I: Introduction<br>1. Introduction to antiviral therapy</p> <p>Section II: Viral infections and transmission<br>2. Emerging viral diseases<br>3. Evolution and transmission of viruses<br>4. Mode of viral infections and transmissions<br>5. Transmission and Intervention Dynamics of SARS-CoV-2<br>6. Sexually transmitted viral infections<br>7. Testing of viral infections<br>8. Electron microscopic methods for virus diagnosis</p> <p>Section III: Antiviral agents and therapeutics<br>9. Virotherapy<br>10. Challenges in designing antiviral agents<br>11. Anti-influenza agents<br>12. Anti-herpes virus agents<br>13. Antiretroviral Therapies<br>14. Rotavirus and anti-rotaviral agents: Trends and advances<br>15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses<br>16. Antiviral agents against flaviviruses<br>17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat <br>18. Herbal drugs to combat viruses<br>19. Strategies for delivery of antiviral agents<br>20. Nanovesicles for delivery of antiviral agents<br>21. Antiviral biomaterials<br>22. Antiviral biomolecules from marine inhabitantsBalasubramanian <br>23. Plant polysaccharides as antiviral agents<br>24. Antiviral peptides against dengue virus<br>25. mRNA vaccines for COVID-19<br>26. Immunotherapy as an emerging and promising tool against viral infections<br>27. Role of nutraceuticals as immunomodulators to combat viruses</p> <p>Section IV: Others<br>28. In vitro and in vivo approaches for evaluating antiviral efficacy<br>29. Clinical trials and regulatory considerations of antiviral agents<br>30. Future perspectives of antiviral therapy</p>